Invention Grant
- Patent Title: JAK inhibition as a novel therapy for preventing tumors in Peutz-Jeghers Syndrome
-
Application No.: US16443386Application Date: 2019-06-17
-
Publication No.: US11234983B2Publication Date: 2022-02-01
- Inventor: Saara Ollila , Tomi Mäkelä , Eva Domenech Moreno
- Applicant: Curingenetics, LLC
- Applicant Address: US CA Ladera Ranch
- Assignee: Curingenetics, LLC
- Current Assignee: Curingenetics, LLC
- Current Assignee Address: US CA Ladera Ranch
- Agency: Maenner & Associates, LLC
- Agent Joseph Maenner
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P35/00 ; A61K9/00
Abstract:
Treatment with the Jak1/2 inhibitor ruxolitinib results in a dramatic decrease in polyposis for organisms with Peutz-Jeghers Syndrome.
Information query
IPC分类:
